Literature DB >> 18565956

Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease.

Bipen D Patel1, Harvey O Coxson, Sreekumar G Pillai, Alvar G N Agustí, Peter M A Calverley, Claudio F Donner, Barry J Make, Nestor L Müller, Stephen I Rennard, Jørgen Vestbo, Emiel F M Wouters, Melanie P Hiorns, Yasutaka Nakano, Patricia G Camp, Paola V Nasute Fauerbach, Nicholas J Screaton, Edward J Campbell, Wayne H Anderson, Peter D Paré, Robert D Levy, Stephen L Lake, Edwin K Silverman, David A Lomas.   

Abstract

RATIONALE: It is unclear whether airway wall thickening and emphysema make independent contributions to airflow limitation in chronic obstructive pulmonary disease (COPD) and whether these phenotypes cluster within families.
OBJECTIVES: To determine whether airway wall thickening and emphysema (1) make independent contributions to the severity of COPD and (2) show independent aggregation in families of individuals with COPD.
METHODS: Index cases with COPD and their smoking siblings underwent spirometry and were offered high-resolution computed tomography scans of the thorax to assess the severity of airway wall thickening and emphysema.
MEASUREMENTS AND MAIN RESULTS: A total of 3,096 individuals were recruited to the study, of whom 1,159 (519 probands and 640 siblings) had technically adequate high-resolution computed tomography scans without significant non-COPD-related thoracic disease. Airway wall thickness correlated with pack-years smoked (P < or = 0.001) and symptoms of chronic bronchitis (P < 0.001). FEV(1) (expressed as % predicted) was independently associated with airway wall thickness at a lumen perimeter of 10 mm (P = 0.0001) and 20 mm (P = 0.0013) and emphysema at -950 Hounsfield units (P < 0.0001). There was independent familial aggregation of both the emphysema (adjusted odds ratio, 2.1; 95% confidence interval, 1.1-4.0; P < or = 0.02) and airway disease phenotypes (P < 0.0001) of COPD.
CONCLUSIONS: Airway wall thickening and emphysema make independent contributions to airflow obstruction in COPD. These phenotypes show independent aggregation within families of individuals with COPD, suggesting that different genetic factors influence these disease processes.

Entities:  

Mesh:

Year:  2008        PMID: 18565956     DOI: 10.1164/rccm.200801-059OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  122 in total

1.  Involvement of surfactant protein D in emphysema revealed by genetic association study.

Authors:  Takeo Ishii; Koichi Hagiwara; Koichiro Kamio; Shinobu Ikeda; Tomio Arai; Makiko Naka Mieno; Toshio Kumasaka; Masaaki Muramatsu; Motoji Sawabe; Akihiko Gemma; Kozui Kida
Journal:  Eur J Hum Genet       Date:  2011-09-21       Impact factor: 4.246

Review 2.  Airway imaging in disease: gimmick or useful tool?

Authors:  Peter D Paré; Taishi Nagano; Harvey O Coxson
Journal:  J Appl Physiol (1985)       Date:  2012-05-17

3.  Airway wall attenuation: a biomarker of airway disease in subjects with COPD.

Authors:  George R Washko; Mark T Dransfield; Raúl San José Estépar; Alejandro Diaz; Shin Matsuoka; Tsuneo Yamashiro; Hiroto Hatabu; Edwin K Silverman; William C Bailey; John J Reilly
Journal:  J Appl Physiol (1985)       Date:  2009-04-30

4.  Quantitative chest tomography in COPD research: chairman's summary.

Authors:  Harvey O Coxson
Journal:  Proc Am Thorac Soc       Date:  2008-12-15

5.  Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.

Authors:  Prescott G Woodruff; R Graham Barr; Eugene Bleecker; Stephanie A Christenson; David Couper; Jeffrey L Curtis; Natalia A Gouskova; Nadia N Hansel; Eric A Hoffman; Richard E Kanner; Eric Kleerup; Stephen C Lazarus; Fernando J Martinez; Robert Paine; Stephen Rennard; Donald P Tashkin; MeiLan K Han
Journal:  N Engl J Med       Date:  2016-05-12       Impact factor: 91.245

6.  Assessing pleiotropy and mediation in genetic loci associated with chronic obstructive pulmonary disease.

Authors:  Margaret M Parker; Sharon M Lutz; Brian D Hobbs; Robert Busch; MerryLynn N McDonald; Peter J Castaldi; Terri H Beaty; John E Hokanson; Edwin K Silverman; Michael H Cho
Journal:  Genet Epidemiol       Date:  2019-02-11       Impact factor: 2.135

7.  Comprehensive stereological assessment of the human lung using multiresolution computed tomography.

Authors:  Dragoş M Vasilescu; André B Phillion; Daisuke Kinose; Stijn E Verleden; Bart M Vanaudenaerde; Geert M Verleden; Dirk Van Raemdonck; Christopher S Stevenson; Cameron J Hague; MeiLan K Han; Joel D Cooper; Tillie-Louise Hackett; James C Hogg
Journal:  J Appl Physiol (1985)       Date:  2020-04-16

8.  Physiological and computed tomographic predictors of outcome from lung volume reduction surgery.

Authors:  George R Washko; Fernando J Martinez; Eric A Hoffman; Stephen H Loring; Raúl San José Estépar; Alejandro A Diaz; Frank C Sciurba; Edwin K Silverman; MeiLan K Han; Malcolm Decamp; John J Reilly
Journal:  Am J Respir Crit Care Med       Date:  2009-12-03       Impact factor: 21.405

9.  Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction.

Authors:  Surya P Bhatt; Jessica C Sieren; Mark T Dransfield; George R Washko; John D Newell; Douglas S Stinson; Gideon K D Zamba; Eric A Hoffman
Journal:  Thorax       Date:  2013-03-23       Impact factor: 9.139

10.  Quantitative computed tomography assessment of airway wall dimensions: current status and potential applications for phenotyping chronic obstructive pulmonary disease.

Authors:  Harvey O Coxson
Journal:  Proc Am Thorac Soc       Date:  2008-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.